← brief for 2026-08-28 · Slowing decline

Association of GLP1-Receptor Agonists With Diabetic Retinopathy.

Article C Peer reviewed Observational

Key takeaways

A study of over 100,000 people with diabetes found those taking GLP1-receptor agonists had a slightly lower risk of eye problems than those on another drug class, but because it is observational, it shows a link — not proof that the drug caused the benefit.

Who did this work

Gonzalez A · Chastain L · Karasik O · Asmar A · Farhangi M · Alvarez CA · Mansi IA

Source

Article · PubMed, the drug frontier · 2026 Aug 27
https://pubmed.ncbi.nlm.nih.gov/42660856/